Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficient Augmented Intelligence Framework for Bladder Lesion Detection.
Eminaga O, Lee TJ, Laurie M, Ge TJ, La V, Long J, Semjonow A, Bogemann M, Lau H, Shkolyar E, Xing L, Liao JC. Eminaga O, et al. Among authors: bogemann m. JCO Clin Cancer Inform. 2023 Sep;7:e2300031. doi: 10.1200/CCI.23.00031. JCO Clin Cancer Inform. 2023. PMID: 37774313 Free PMC article.
Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial.
Hussain M, Tombal B, Saad F, Fizazi K, Sternberg CN, Crawford ED, Shore N, Kopyltsov E, Kalebasty AR, Bögemann M, Ye D, Cruz F, Suzuki H, Kapur S, Srinivasan S, Verholen F, Kuss I, Joensuu H, Smith MR. Hussain M, et al. Among authors: bogemann m. J Clin Oncol. 2023 Jul 10;41(20):3595-3607. doi: 10.1200/JCO.23.00041. Epub 2023 Feb 16. J Clin Oncol. 2023. PMID: 36795843 Clinical Trial.
[Emergencies in cancer immunotherapy].
Handke A, Hilser T, Bögemann M, Schlack K, Grünwald V. Handke A, et al. Among authors: bogemann m. Aktuelle Urol. 2024 Feb;55(1):28-37. doi: 10.1055/a-2128-4849. Epub 2023 Aug 22. Aktuelle Urol. 2024. PMID: 37607581 German.
Early side effects and first results of radioligand therapy with (177)Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study.
Ahmadzadehfar H, Rahbar K, Kürpig S, Bögemann M, Claesener M, Eppard E, Gärtner F, Rogenhofer S, Schäfers M, Essler M. Ahmadzadehfar H, et al. Among authors: bogemann m. EJNMMI Res. 2015 Dec;5(1):114. doi: 10.1186/s13550-015-0114-2. Epub 2015 Jun 20. EJNMMI Res. 2015. PMID: 26099227 Free PMC article.
103 results